Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 35.64M P/E - EPS this Y 23.20% Ern Qtrly Grth -
Income -27.63M Forward P/E -1.39 EPS next Y 1.20% 50D Avg Chg -15.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -33.00%
Dividend N/A Price/Book 1.11 EPS next 5Y - 52W High Chg -64.00%
Recommedations 1.70 Quick Ratio 1.77 Shares Outstanding 2.11M 52W Low Chg 8.00%
Insider Own 0.56% ROA -45.16% Shares Float 29.20M Beta 0.94
Inst Own 21.49% ROE -103.51% Shares Shorted/Prior 9.29K/99.24K Price 0.68
Gross Margin - Profit Margin - Avg. Volume 42,411 Target Price 125.13
Oper. Margin - Earnings Date May 15 Volume 137,843 Change -9.29%
About NuCana plc

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase 1b/2 study in patients with metastatic colorectal cancer, Phase 2 clinical trial for the second-line treatment of patients with advanced colorectal cancer, and Phase 1b/2 modular clinical trial for patients with advanced solid tumors and lung cancer. It is also developing NUC-7738, a ProTide transformation of 3'-deoxyadenosine, which is in the Phase 2 part of a Phase 1/2 clinical trial for patients with advanced solid tumors. The company has an assignment, license, and collaboration agreement with Cardiff ProTides Ltd to discover, drug design, and in vitro screen purine and pyrimidine-based nucleosides as potential drug candidates. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.

NuCana plc News
05/01/24 NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
04/16/24 NuCana Announces Completion of ADS Ratio Change
04/09/24 NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
03/27/24 NuCana Announces Plan to Implement ADS Ratio Change
03/20/24 NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
03/14/24 NuCana (NASDAQ:NCNA) Will Have To Spend Its Cash Wisely
02/27/24 NuCana to Present at TD Cowen’s 44th Annual Health Care Conference
02/06/24 NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
11/16/23 NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update
11/10/23 NuCana Announces Listing Transfer to Nasdaq Capital Market
11/08/23 NuCana to Present at the Jefferies London Healthcare Conference
11/01/23 NuCana to Participate in the Truist Securities 2023 BioPharma Symposium
10/16/23 NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
10/13/23 NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
09/28/23 Bears are Losing Control Over NuCana PLC Sponsored ADR (NCNA), Here's Why It's a 'Buy' Now
09/18/23 NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023
08/31/23 Here's Why We're Watching NuCana's (NASDAQ:NCNA) Cash Burn Situation
08/16/23 NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update
06/01/23 NuCana to Present at the Jefferies Healthcare Conference
05/17/23 NuCana Reports First Quarter 2023 Financial Results and Provides Business Update
NCNA Chatroom

User Image Yousef89 Posted - 14 hours ago

$NCNA Hi… Is there any thing new ? https://ir.nucana.com/static-files/c613e8ce-1cdc-491a-9430-79369c48b6f7

User Image Camiam3333 Posted - 2 days ago

$NCNA

User Image MihaRS13 Posted - 2 days ago

$NCNA

User Image Stock_Titan Posted - 2 days ago

$NCNA NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement https://www.stocktitan.net/news/NCNA/nu-cana-regains-compliance-with-nasdaq-minimum-bid-price-wq5e6jew12dz.html

User Image RollingDollar Posted - 04/29/24

$NCNA

User Image Stocks4thought Posted - 04/23/24

$NCNA ANYONE studied this story?

User Image RollingDollar Posted - 04/22/24

$NCNA

User Image MGAP Posted - 04/19/24

$NCNA low float

User Image trader87 Posted - 04/19/24

$NCNA another swing here,pt 5.50-6$ Gl

User Image ALLCAPINVESTOR Posted - 04/18/24

$NCNA few days past the RS and historically March/April have been awful for NCNA data releases over the last 20 years. We havent received anything yet!!! But we are fast approaching May with 8 months left to release no less than 5 studies. Cash on hand barely gets them to Dec. and historically May, June, July, Sept and Oct are good capital raise months. My point is that odds are we have some good studies before we hear about the bad studies bc of the capital raise needs. The question is how much value do we give these phase 2 studies and does anyone know if these studies and their targeted patient population dire enough for the FDA to fast tract these drugs?

User Image tintinnabulation26 Posted - 04/18/24

$NCNA Really hoping the trendline on the hour isn't accurate

User Image pee_dee Posted - 04/16/24

$NCNA even with good results, no money to do anything with it. $3 by end of week. Another R/S by year’s end. Best thing they can hope for is a $50-100M buyout. Don’t give them your money.

User Image bhos Posted - 04/16/24

$NCNA Now is the time for this company. They have this year to show something significant. I'm guessing they will. It's been absolutely brutal for investors for a long while.

User Image Panicmode Posted - 04/16/24

$NCNA was expecting more idiots to show up and pump something they don't have a clue about.. 🙄

User Image G101SPM Posted - 04/16/24

$NCNA $3.90 ask.... BUY/NEW LONG POSITION carries SPM 86.12 tag to EXIT at $6.00 in near term

User Image TA_Kongen Posted - 04/16/24

$NCNA Cash running low here.

User Image frontiere Posted - 04/16/24

$NCNA now that NuCana a 2.1m shares outst low float (free float << shares outst) watch and wait for the 🧨🎇 🚀 boom on a positive PR re NUC-3373 Ph 1b/2 (NuTide:302) open label study of NUFIRI + bev and NUFOX + bev for the second-line treatment of patients with advanced colorectal cancer — last update April 3rd, trial status marked Completed on 2024-03-21. Source: https://clinicaltrials.gov/study/NCT03428958

User Image Car_key Posted - 04/16/24

$NCNA What is actual float after RS?

User Image Noname127 Posted - 04/16/24

$NCNA this company has fucking wrecked my portfolio. I hope it goes bankrupt and they lose everything the fuckers..

User Image Dassasmaklais Posted - 04/16/24

$NCNA

User Image rkrause Posted - 04/16/24

$NCNA Why does it say high $24 4/17/24 on etrade

User Image saud89 Posted - 04/16/24

$NCNA Average $16 🙃

User Image rkrause Posted - 04/16/24

$NCNA I just panic was dropping and I sold 77 shares for 416. My 24000 shares went to 977 overnight.That's bullshit

User Image Wolfofwannabe Posted - 04/16/24

$NCNA Ahh 💩 forgot about R/S

User Image Caroline_did_it_not_me Posted - 04/16/24

$NCNA is ratio change a euphemism for reverse split

User Image Qwikkzz Posted - 04/16/24

$NCNA is this an RS?

User Image Stock_Titan Posted - 04/16/24

$NCNA NuCana Announces Completion of ADS Ratio Change https://www.stocktitan.net/news/NCNA/nu-cana-announces-completion-of-ads-ratio-k4dikuibmjym.html

User Image tintinnabulation26 Posted - 04/15/24

$NCNA Fvck this company, couldn't even prop it a little to get a better entry for bigger buyers, most likely just pop and drops from here on out

User Image 321rip Posted - 04/15/24

@Paraboljoker $HUBC, Thoughts on $NCNA -19%?

User Image tradethehalt Posted - 04/15/24

$NCNA trade halt (T1) was alerted to our Members at 7:50pm EDT. Halt price: $0.19 Vol: 805.64K.

Analyst Ratings
Oppenheimer Outperform Apr 1, 24
Oppenheimer Outperform Nov 21, 23
Truist Securities Buy Sep 6, 23
Oppenheimer Outperform Aug 18, 23
Oppenheimer Outperform May 22, 23
Jefferies Buy Sep 22, 22
Cowen & Co. Market Perform Mar 3, 22
HC Wainwright & Co. Buy Nov 24, 21
HC Wainwright & Co. Buy Dec 1, 20